CD44 and neoplasm: Other potentially active biological tumor markers predicting resistance to NCRT are cluster of differentiation 44 (CD44) and the Hedgehog pathway markers receptor protein patched homolog 1 (PTCH1) and ligand Sonic Hedgehog (SHH) [24].